|
|
||||||||
Sign In to gain access to subscriptions and/or personal tools. |
|||||||||
Most-read rankings are recalculated at the beginning of the month and are based on full-text and pdf views.
| 1. | Carol Addy, Susie Li, Nancy Agrawal, Julie Stone, Anup Majumdar, Ling Zhong, Hankun Li, Jinyu Yuan, Andrea Maes, Paul Rothenberg, Josee Cote, Kim Rosko, Corinne Cummings, Steven Warrington, Malcolm Boyce, Keith Gottesdiener, Aubrey Stoch, John Wagner | ||
| Safety, Tolerability, Pharmacokinetics, and Pharmacodynamic Properties of Taranabant, a Novel Selective Cannabinoid-1 Receptor Inverse Agonist, for the Treatment of Obesity: Results From a Double-Blind, Placebo-Controlled, Single Oral Dose Study in Healthy Volunteers | |||
|---|---|---|---|
|
J Clin Pharmacol Apr 01, 2008; 48: 418-427.
(In "Pharmacokinetics and Pharmacodynamics") |
|||
| 2. | Bradley L. Urquhart, Rommel G. Tirona, Richard B. Kim | ||
| Nuclear Receptors and the Regulation of Drug-Metabolizing Enzymes and Drug Transporters: Implications for Interindividual Variability in Response to Drugs | |||
|
J Clin Pharmacol May 01, 2007; 47: 566-578.
(In "Drug Metabolism and Transport") |
|||
| 3. | Amita Joshi, Robert Bauer, Peter Kuebler, Mark White, Cecelia Leddy, Peter Compton, Marvin Garovoy, Paul Kwon, Patricia Walicke, Russell Dedrick | ||
| An Overview of the Pharmacokinetics and Pharmacodynamics of Efalizumab: A Monoclonal Antibody Approved for Use in Psoriasis | |||
|
J Clin Pharmacol Jan 01, 2006; 46: 10-20.
(In "Therapeutic Review") |
|||
| 4. | Shiew-Mei Huang, John M. Strong, Lei Zhang, Kellie S. Reynolds, Srikanth Nallani, Robert Temple, Sophia Abraham, Sayed Al Habet, Raman K. Baweja, Gilbert J. Burckart, Sang Chung, Philip Colangelo, David Frucht, Martin D. Green, Paul Hepp, Elena Karnaukhova, Hon-Sum Ko, Jang-Ik Lee, Patrick J. Marroum, Janet M. Norden, Wei Qiu, Atiqur Rahman, Soloman Sobel, Toni Stifano, Kenneth Thummel, Xiao-xiong Wei, Sally Yasuda, Jenny H. Zheng, Hong Zhao, Lawrence J. Lesko | ||
| New Era in Drug Interaction Evaluation: US Food and Drug Administration Update on CYP Enzymes, Transporters, and the Guidance Process | |||
|
J Clin Pharmacol Mar 31, 2008; doi: 10.1177/0091270007312153.
(In "Articles") |
|||
| 5. | David S. Small, Nagy A. Farid, Christopher D. Payne, Govinda J. Weerakkody, Ying G. Li, John T. Brandt, Daniel E. Salazar, Kenneth J. Winters | ||
| Effects of the Proton Pump Inhibitor Lansoprazole on the Pharmacokinetics and Pharmacodynamics of Prasugrel and Clopidogrel | |||
|
J Clin Pharmacol Apr 01, 2008; 48: 475-484.
(In "Drug Interactions") |
|||
| [Next 5 Articles] | |||
= from the current issue
Last Updated: 05/03/2008 10:53:46
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |